跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SPEVIGO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SPEVIGO
Authorized
STANDARD
SPEVIGO
LEO Pharma Inc
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
c9eab50f58db59c8
Company
LEO Pharma Inc
Type
Standard
Approval Details
Approval Id
c9eab50f58db59c8
Drug Approval Canada Name
SPEVIGO
Product Name
SPEVIGO
Status
Approved
Status Date
2026-03-26
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
SCHEDULE D , PRESCRIPTION
Ahfs
84:06.28
Atc Original
L04AC22 SPESOLIMAB
Aig Number
0164521002
Company Name
LEO Pharma Inc
Company Address
6 Adelaide Street East, Suite 200 Toronto Ontario Canada M5C 1H6
Company Detail Path
/organization/leo-pharma-inc
Company Information
Pharmaceutical Company Name
LEO Pharma Inc
Country Name
Canada
Province Name
Ontario
City Name
thornhill,ontario,country_ca
Address
400-123 Commerce Valley Dr E
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
c9eab50f58db59c8
Type
Standard
Back to Health Canada Approvals